BIOVELA NT - Company finances
|
EUR
|
2020
From: 2020-03-04
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | 21,469 | 24,254 | 39,180 | 15,075 | 39,188 | 38,400 |
| Profit before tax | -107,954 | -172,052 | -165,441 | -149,852 | -205,740 | -164,652 |
| Net profit | -107,954 | -172,052 | -165,441 | -149,852 | -205,740 | -164,652 |
| Equity | 2,834,329 | 2,662,277 | 2,496,836 | 1,886,984 | 373,574 | 208,922 |
| Liabilities | 116,739 | 95,923 | 814,313 | 1,560,724 | 4,023,148 | 4,144,239 |
| Non-current assets | 2,925,576 | 2,747,559 | 3,125,212 | 3,437,049 | 4,383,221 | 4,327,937 |
| Current assets | 24,400 | 9,954 | 185,341 | 9,230 | 11,687 | 23,401 |
| Total assets | 2,949,976 | 2,757,513 | 3,310,553 | 3,446,279 | 4,394,908 | 4,351,338 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | 76,310 | 22,039 | 12,198 |
|
Financial indicators
|
||||||
| Revenue change y/y | - | +13.0% | +61.5% | -61.5% | +160.0% | -2.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -3.7% | -6.2% | -5.0% | -4.3% | -4.7% | -3.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -3.8% | -6.5% | -6.6% | -7.9% | -55.1% | -78.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -502.8% | -709.4% | -422.3% | -994.0% | -525.0% | -428.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -502.8% | -709.4% | -422.3% | -994.0% | -525.0% | -428.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.0 | 0.3 | 0.8 | 10.8 | 19.8 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 21,469 | 24,254 | 39,180 | 15,075 | 39,188 | 38,400 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
BIOVELA NT - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-05-16 | 2024-06-02 | 0.02 |
| 2024-04-23 | 2024-05-13 | 0.02 |
| 2024-02-19 | 2024-02-27 | 5.32 |
BIOVELA NT - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-07-28 | 2025-08-12 | 0.02 |
| 2025-06-28 | 2025-07-24 | 0.13 |
| 2025-06-19 | 2025-06-23 | 0.37 |
| 2025-05-29 | 2025-06-12 | 0.05 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
BIOVELA NT, UAB (code 305493393) is a Private Limited Liability Company operating in the rental and operating of own or leased real estate segment. In 2025, the company generated EUR 38.4K in revenue, broadly in line with EUR 39.2K in 2024 and well above EUR 15.1K in 2023. Over the two-year period, revenue expanded materially from the 2023 base, although growth slowed in 2025. The company remained loss-making, with net loss narrowing to EUR 164.7K in 2025 from EUR 205.7K in 2024, after EUR 149.9K in 2023. Profitability was weak, as losses continued to exceed revenue by a wide margin. At the end of 2025, total assets stood at EUR 4.35M, of which EUR 4.33M were long-term assets and EUR 23.4K short-term assets. Equity amounted to EUR 208.9K, compared with liabilities of EUR 4.14M, pointing to a highly leveraged balance sheet and an equity ratio of 4.8%. ROE was -78.8%, ROA -3.8%, and asset turnover remained very low at 0.01x. Revenue per employee was EUR 38.4K.